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Introduction
A recent systematic review of treatments of Eustachian tube
dysfunction commissioned by the UK NIHR Health Tech-
nology Assessment (HTA) Programme revealed that an
important limitation with the available evidence is a lack of
consensus on the definition and diagnosis of this disorder.1
The HTA report recommended that key to advancing
research in this field is achieving consensus on diagnostic
criteria for Eustachian tube dysfunction (to identify eligi-
ble patients for future trials) and on important clinical
outcomes.
To address this need, an international forum of scientists
and physicians with expertise in the field of Eustachian tube
disorders met at a workshop in Amsterdam on 21 June 2014
and was tasked to come to an agreement on the definition,
clinical presentation and diagnosis of Eustachian tube
dysfunction, and areas for future research. This study
summarises the outcomes of that meeting.
Workshop design
A purposive sample of International experts in the field was
brought together, spanning primary to tertiary care, and
across the translational research pathway, frommolecular to
implementation science specialists.
The panel used the systematic review conducted for the
UK NIHR HTA1 as the starting point. Consensus was
achieved through a series of presentations by individual
panel members and discussions around themes of function
and dysfunction of the Eustachian tube, definitions, symp-
toms, signs and clinical investigation of Eustachian tube
dysfunction. This study represents the consensus group
opinion and was drafted and revised using an iterative
process including all panel members.
The contribution of Eustachian tube dysfunction to
mucosal or squamous forms of otitis media and the
effectiveness of treatments for Eustachian tube dysfunction
were outside the remit of this workshop.We did not consider
disease in childhood, and so this statement refers only to
disease in adults.
Normal function of the Eustachian tube
The panel agreed that the Eustachian tube has unique
functions and can be thought of as an organ; failure of its
functions comprises dysfunction. The functions of the
Eustachian tube are as follows2:
1 pressure equalisation and ventilation of the middle ear,
2 mucociliary clearance of secretions from the middle ear,
3 protection of the middle ear from sounds, and from
pathogens and secretions from the nasopharynx.
Pressure in the middle ear is maintained through two
mechanisms: middle ear mucosal gas exchange and opening
of the Eustachian tube to equilibrate pressure with that in the
nasopharynx.3 The relative contribution of these two mech-
anisms tonormalmiddle ear ventilation isnot known.Recent
evidence suggests that, in the healthy middle ear, pressure
slowlydecreases, andperiodicopeningof theEustachian tube
restores the middle ear towards atmospheric pressure.4
Clearance of middle ear secretions occurs through both a
muscular peristaltic action in the Eustachian tube and
through the mucociliary escalator. When functioning nor-
mally, the Eustachian tube protects the middle ear against
inflammation and infection by viruses, bacteria and gastro-
oesophageal reflux.
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Definition of Eustachian tube dysfunction
The panel agreed that Eustachian tube dysfunction is a
syndrome with a constellation of signs and symptoms
suggestive of dysfunction of the Eustachian tube. This does
not preclude that Eustachian tube dysfunction can also be a
mechanism to middle ear disease.
Although in a strict sense Eustachian tube dysfunction is a
failure to perform any of the Eustachian tube functions, in
clinical practice, Eustachian tube dysfunction usually refers to
aproblemwiththeventilatory functionof theEustachian tube.
As such, Eustachian tube dysfunction is defined by symptoms
and signs of pressure dysregulation in the middle ear.
The panel agreed to distinguish acute Eustachian tube
dysfunction, transient with symptoms and signs for less than
3 months, from chronic dysfunction, symptoms and signs
for more than 3 months. We agreed that there are three
subtypes of Eustachian tube dysfunction:
1 dilatory Eustachian tube dysfunction,
2 baro-challenge-induced Eustachian tube dysfunction,
3 patulous Eustachian tube dysfunction.
Dilatory Eustachian tube dysfunction can be broken down
as follows:
1 functional obstruction,
2 dynamic dysfunction (muscular failure),
3 anatomical obstruction.
Current ICD-10 codes for Eustachian tube dysfunction
include the following: H68.0 inflammatory dilatory dys-
function of the Eustachian tube, H68.1 obstruction of the
Eustachian tube, H69.0 patulous Eustachian tube, H69.8
other defined Eustachian tube dysfunction and H69.9 non-
defined Eustachian tube dysfunction. We propose that
future coding should consider the new classification system
suggested here.
Clinical history: symptoms of Eustachian tube
dysfunction
To diagnose Eustachian tube dysfunction, the patient must
present with symptoms of pressure disequilibrium in the
affected ear, specifically symptoms of ‘aural fullness’ or
‘popping’ or discomfort/pain. Patients may also report
pressure, clogged or ‘under water’ sensation, crackling,
ringing, autophony and muffled hearing.
Acute dilatory Eustachian tube dysfunction is often
preceded by an upper respiratory tract infection, or some-
times by an exacerbation of allergic rhinitis, which presum-
ably causes inflammation in the Eustachian tube orifice or
lumen. Some patients may have a prior history of otitis
media. It is not clear whether the aetiology of chronic
dilatory Eustachian tube dysfunction is an extension of the
same pathology underlying acute dilatory Eustachian tube
dysfunction, or whether other pathologicalmechanismsmay
underlie these symptoms. Some patients with dilatory
Eustachian tube dysfunction may report repeated Valsalva
or jaw-thrust manoeuvres in an attempt to equalise negative
middle ear pressure; others describe altered hearing or
tinnitus.
In baro-challenge-induced Eustachian tube dysfunction,
symptoms of aural fullness, popping or discomfort/pain
occur, or are initiated, under conditions of alteration to the
ambient pressure. Typically symptoms may manifest when
scuba-diving or on descent from altitude, but can also occur
under conditions of less marked ambient pressure
fluctuation. Patients are typically asymptomatic once they
return to ground level, although significant baro-challenge
may cause temporary middle ear effusion or haemotympa-
num.
Patulous Eustachian tube dysfunction presents with
symptoms of aural fullness and autophony. Symptoms
may be better in the supine position or during upper
respiratory tract infection.4 They may worsen during exer-
cise. Patulous Eustachian tube dysfunction is thought to be
caused by an abnormally patent Eustachian tube; as such, it
may be precipitated by recent weight loss, although in the
majority of cases no underlying precipitating event is
evident. Some patients with patulous Eustachian tube
dysfunction will habitually sniff.
Clinical assessment: signs of Eustachian tube
dysfunction
Clinical assessment will vary depending upon what investi-
gations are readily available (e.g. in primary care, tympa-
nometry is rarely available). Ideally assessment should
include the following:
1 otoscopy or otomicroscopy,
2 tympanometry,
3 Rinne’s and Weber’s tuning fork tests or pure tone
audiometry,
4 nasopharyngoscopy (to visualise the opening of the
Eustachian tube).
It was agreed that to diagnose dilatory Eustachian tube
dysfunction, patient-reported symptoms should go together
with evidence of negative pressure in the middle ear as
assessed by clinical assessment, either as follows:
1 otoscopic or otomicroscopic evidence of tympanic mem-
brane retraction and/or
2 tympanogram indicating negative middle ear pressure.
An ability to auto-inflate the middle ear on Valsalva or
Toynbee manoeuvre confirms some degree of patency of the
Eustachian tube, but the panel felt that ability to auto-inflate
is not sufficiently sensitive or specific for Eustachian tube
dysfunction to have clinical utility.
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In baro-challenge-induced Eustachian tube dysfunction,
otoscopy and tympanometry may be normal at normal
ambient pressure, and so diagnosis relies on patient history.
In some cases of baro-challenge-induced Eustachian tube
dysfunction, middle ear effusion or haemotympanum may
be evident.
In Patulous Eustachian tube dysfunction, symptoms go
together with evidence on otoscopy or tympanometry of
tympanic membrane excursion with breathing.4
Tympanometry may not be available in a primary care
setting, in which case diagnosis of Eustachian tube dysfunc-
tion is confirmed by abnormal otoscopy or may be
presumptive. If symptoms of Eustachian tube dysfunction
are chronic (more than 3 months) and/or troublesome,
referral to secondary care should be considered to confirm
the diagnosis and to determine its cause.
Pure tone audiometry should include air and bone
conduction thresholds. A mild or moderate conductive
hearing loss may be found in some patients with Eustachian
tube dysfunction. In primary care, tuning fork tests (Rinne’s
and Weber’s tests) may be used as a substitute for audiom-
etry, although these tests are less reliable.
Nasopharyngoscopy is usually only available in secondary
care. Examination may reveal a cause for Eustachian tube
dysfunction, for example inflammation adjacent to the
Eustachian tube orifice, or (rarely) neoplasms, scarring or
other lesions.
The panel agreed that radiological evaluation does not
routinely play a role in diagnosis of Eustachian tube
dysfunction, and should be reserved for cases where
additional or alternate pathology is suspected based upon
history or examination.
The combination of clinical symptoms and signs enables a
diagnostic algorithm for the diagnosis and subclassification
of Eustachian tube dysfunction (Fig. 1).
Role of Eustachian tube function tests and scoring
systems
The panel agreed that at the current time, there is no
universally accepted set of patient-reported symptom scores,
functional tests or scoring systems to diagnose Eustachian
tube dysfunction, and the diagnosis should therefore at this
stage rely on the clinical observations (symptoms and signs)
detailed above.
A number of tests of the ventilatory function of the
Eustachian tube have been devised, including tuboma-
nometry, sonotubometry, nine-step inflation–deflation
test and pressure chamber tests. At the current time, the
equipment these tests require is not widely available, and
their accuracy and validity is unclear,5 but they can be
useful research tools.
TheEustachianTubeDysfunctionQuestionnaire (ETDQ-
7)6 scores symptoms of Eustachian tube dysfunction and is
the only patient-reported outcomes tool to have undergone
initial validation studies. The Eustachian Tube Score (ETS)
and its extension the ETS-77 combine subjective (clicking
sound when swallowing, Valsalva) and objective (tuboma-
nometry, tympanometry) measures of Eustachian tube
function.
Fig. 1. Symptoms and signs used to define Eustachian tube dysfunction (ETD) and the subtypes of acute ETD, chronic ETD, baro-challenge-
induced ETD and patulous Eustachian tube.
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The panel agreed that there is a need for wider experience
in the use of these instruments across centres, and for
validation of these instruments using the criteria for
diagnosis recommended in this study.
Outcome measures
The panel agreed that in any future clinical trials, clinical
outcomes should be assessed at baseline and in the short term
(defined as 6 weeks to 3 months) and the long-term term
(defined as 6–12 months), and should include assessment of
patient-reported symptoms, otoscopy, tympanometry and
pure tone audiometry.
Differential diagnosis
Eustachian tube dysfunction should not be used to describe
disease more properly classified as otitis media, including
chronic otitis media with effusion (glue ear), chronic
suppurative otitis media, tympanic membrane retraction
and cholesteatoma. Whereas ventilatory dysfunction of the
Eustachian tubemay contribute to the onset or persistence of
these types of otitis media, the relative importance of this
contribution is amatter of debate and a debate outside of the
remit of this work.
A number of other disorders can present with symptoms
similar to Eustachian tube dysfunction. Patients with
cochlear hydrops may describe periodic unilateral pressure
sensation associated with altered hearing that typically lasts a
few hours. Patients with temporomandibular joint (TMJ)
dysfunction describe discomfort in front of and around the
ear, typically unilateral, and in some cases associated with
clicking or popping noises and altered hearing or tinnitus.
Although there are no clear diagnostic criteria for TMJ
dysfunction, aggravation of pain by manipulation or func-
tion of the jaw is a cardinal sign. In diagnosing patulous
Eustachian tube dysfunction, other causes of autophony
should be considered, including a fistula of the inner ear, for
example due to superior semicircular canal dehiscence.
Tullio phenomenon may suggest an inner ear fistula,
although in isolation this sign is not reliable for diagnosis.
Recommendations for future research
The definitions, diagnostic criteria and subclassification of
Eustachian tube dysfunction presented in this consensus
statement can be used to inform future research in this field.
In particular, consensus and consistency in disease definition
should enable better studies of the epidemiology of Eusta-
chian tube dysfunction, and clear inclusion criteria and
outcome measures for new clinical trials of treatments for
Eustachian tube dysfunction.
Areas for future research include the following:
1 The epidemiology of Eustachian tube dysfunction,
including prevalence of associated symptoms in the com-
munity, primary care, and hospital populations, natural
history, psychosocial impact and relation to preceding or
subsequent otitis media.
2 Further work to develop and validate patient-reported
symptom scores and subjective and objective pressure tests,
as instruments to aid diagnosis and to assess disease severity
and treatment outcomes.
3 Working with patients and the public to develop a core set
of outcome measures to monitor the effects of treatments of
Eustachian tube dysfunction in a research and clinical
setting.
4 Randomised controlled trials of treatments for Eustachian
tube dysfunction, incorporating recommendations regard-
ing the definitions, subtypes, diagnostic criteria and out-
come measures of Eustachian tube dysfunction presented
here.
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Keypoints
• A recent systematic review showed that there is wide
variation in diagnostic criteria for Eustachian tube
dysfunction.
• An expert panel was convened to define this disorder in
adults, and agreed that there are probably three
subtypes of Eustachian tube dysfunction: dilatory,
baro-challenge induced, and patulous.
• Eustachian tube dysfunction presents with symptoms
of pressure disequilibrium in the affected ear(s).
• In dilatory dysfunction there are signs on otoscopy or
tympanometry of negative middle ear pressure. In
baro-challenge induced dysfunction, symptoms occur
only on changes to ambient pressure. In patulous
dysfunction there is otoscopic or tympanometric
evidence of excursion of the tympanic membrane with
breathing.
• The diagnostic categories and criteria detailed in this
paper may be used in future studies of epidemiology,
psychosocial impact, and treatment.
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